Johnson & Johnson logo

Johnson & Johnson (JNJ)

Market Closed
17 Jan, 20:00
NYSE NYSE
$
147. 03
-0.74
-0.5%
Pre Market
$
147. 30
+0.27 +0.18%
356.43B Market Cap
29.06 P/E Ratio
0.33% Div Yield
10,680,500 Volume
9.91 Eps
$ 147.77
Previous Close
Day Range
146.61 148.38
Year Range
140.68 168.85
Earnings results expected in 1 days

Summary

JNJ closed Friday lower at $147.03, a decrease of 0.5% from Thursday's close, completing a monthly increase of 1.24% or $1.8. Over the past 12 months, JNJ stock gained 1.24%.
JNJ pays dividends to its shareholders, with the most recent payment made on Dec 10, 2024. The next announced payment will be in In 1 month on Mar 04, 2025 for a total of $1.24.
The last earnings report, released on Oct 15, 2024, exceeded the consensus estimates by 0.21%. On average, the company has surpassed earnings expectations by 0.13%, based on the last three reports. The next scheduled earnings report is due on Jan 21, 2025.
The stock of the company had never split.
The company's stock is traded on 18 different exchanges and in various currencies, with the primary listing on NYSE (USD).
Want to track JNJ and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

JNJ Chart

FAQ

What Is the Johnson & Johnson(JNJ) Stock Price Today?

The JNJ stock price today is $147.03.

What Stock Exchange Does Johnson & Johnson Trade On?

Johnson & Johnson is listed and trades on the NYSE.

What Is the Stock Symbol for Johnson & Johnson?

The stock symbol for Johnson & Johnson is "JNJ".

Does Johnson & Johnson Pay Dividends? What's The Current Dividend Yield?

JNJ is not paying dividends to its shareholders.

What Is the Johnson & Johnson Market Cap?

As of today, Johnson & Johnson market cap is 356.43B.

What is Johnson & Johnson Earnings Per Share?

The Johnson & Johnson EPS is 0.

What Is the Next Johnson & Johnson Earnings Date?

Johnson & Johnson will release its next earnings report on Jan 21, 2025.

Did Johnson & Johnson had any splits?

No, Johnson & Johnson has never had a stock split.

Johnson & Johnson Profile

Drug Manufacturers - General Industry
Healthcare Sector
Mr. Joaquin Duato CEO
NYSE Exchange
US4781601046 ISIN
United States Country
131,900 Employees
18 Feb 2025 Last Dividend
- Last Split
- IPO Date

Overview

Johnson & Johnson, a renowned entity in the healthcare sector, operates globally with a broad focus on research, development, manufacturing, and sales of healthcare products. The company is structured in multiple segments, primarily Innovative Medicine and MedTech, catering to a vast array of therapeutic areas and medical needs. Founded in 1886, the company is headquartered in New Brunswick, New Jersey, illustrating a longstanding presence and commitment to healthcare innovation and advancement. Through its extensive product line and diversified service offerings, Johnson & Johnson reaches a wide audience, including retailers, wholesalers, distributors, hospitals, and healthcare professionals, providing prescription and non-prescription products alike.

Products and Services

The company's portfolio is divided into two main segments, each encompassing a variety of products and services designed to meet the complex demands of modern healthcare:

  • Innovative Medicine:

    This segment includes a range of products for different therapeutic areas. These encompass immunology (covering diseases like rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis), infectious diseases (including HIV/AIDS treatment), neuroscience (targeting mood disorders, neurodegenerative disorders, schizophrenia), oncology (focused on cancers such as prostate, lung, bladder, and hematologic malignancies), cardiovascular and metabolism (addressing conditions like thrombosis, diabetes, and macular degeneration), and pulmonary hypertension, specifically pulmonary arterial hypertension.

  • MedTech:

    This segment offers products and technologies across a range of medical fields. Interventional Solutions include electrophysiology products for heart rhythm disorders and technologies for severe coronary artery disease treatment. The neurovascular care line focuses on treating hemorrhagic and ischemic strokes. Orthopaedics products support treatments for hips, knees, trauma, spine, and sports injuries. The surgery portfolio covers advanced and general surgery technologies and solutions for breast aesthetics and ear, nose, and throat procedures. Additionally, MedTech offers visual health products like ACUVUE Brand contact lenses and TECNIS intraocular lenses for cataract surgery.

Contact Information

Address: One Johnson & Johnson Plaza
Phone: 732 524 0400